| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunohistochemistry - paraffin section; mouse; fig 3
| Su R, Strug M, Jeong J, Miele L, Fazleabas A. Aberrant activation of canonical Notch1 signaling in the mouse uterus decreases progesterone receptor by hypermethylation and leads to infertility. Proc Natl Acad Sci U S A. 2016;113:2300-5 pubmed publisher |
- immunohistochemistry - paraffin section; human; 1:200
| Feng Q, Zhang Z, Shea M, Creighton C, Coarfa C, Hilsenbeck S, et al. An epigenomic approach to therapy for tamoxifen-resistant breast cancer. Cell Res. 2014;24:809-19 pubmed publisher |
| Joseph J, Darimont B, Zhou W, Arrazate A, Young A, Ingalla E, et al. The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer. elife. 2016;5: pubmed publisher |
| Zhao X, Malhotra G, Band H, Band V. Derivation of myoepithelial progenitor cells from bipotent mammary stem/progenitor cells. PLoS ONE. 2012;7:e35338 pubmed publisher |
| Chan S, Vermi W, Luo J, Lucini L, Rickert C, Fowler A, et al. STAT1-deficient mice spontaneously develop estrogen receptor ?-positive luminal mammary carcinomas. Breast Cancer Res. 2012;14:R16 pubmed |
| Ellison Zelski S, Alarid E. Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor. Mol Cancer. 2010;9:263 pubmed publisher |
| Kocanova S, Kerr E, Rafique S, Boyle S, Katz E, Caze Subra S, et al. Activation of estrogen-responsive genes does not require their nuclear co-localization. PLoS Genet. 2010;6:e1000922 pubmed publisher |
| Wortham N, Ahamed E, Nicol S, Thomas R, Periyasamy M, Jiang J, et al. The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancer. Oncogene. 2009;28:4053-64 pubmed publisher |
